Full text is available at the source.
Abstract
Upregulation of the chromatin remodeler BAZ2B is linked to metabolic dysfunction-associated steatohepatitis (MASH) pathology in patients.
- Liver aging increases vulnerability to MASH with fibrosis.
- The epigenetic mechanism involving BAZ2B connects liver aging to MASH fibrosis.
- Genetic removal or targeted reduction of Baz2b in mice reduces hepatocyte senescence and MASH fibrosis.
- Preservation of PPARα-mediated lipid metabolism is impaired in aged and MASH mouse livers.
- BAZ2B downregulates PPARα signaling pathway genes by binding to their promoters and decreasing chromatin accessibility.
Simplified